Yuika Suzuki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Yuika Suzuki has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Masashi Akiyama
Department of Dermatology Nagoya University Graduate School of Medicine Nagoya Japan
7 shared publications - Takuya Takeichi
Department of Dermatology Nagoya University Graduate School of Medicine Nagoya Aichi Japan
5 shared publications - Yoshinao Muro
Department of Dermatology Nagoya University Graduate School of Medicine Nagoya Aichi Japan
4 shared publications Fumie Kinoshita
Data Science Division, Data Coordinating Center, Department of Advanced Medicine Nagoya University Hospital Nagoya Japan
2 shared publicationsKana Tanahashi
Department of Dermatology, Nagoya University Graduate School of Medicine , Nagoya
2 shared publications- Kana Tanahashi
Department of Dermatology Nagoya University Graduate School of Medicine Nagoya Japan
2 shared publications
Latest Publications
- 22 July 2025
- Published by Wiley in The Journal of Dermatology
- Vol. 52 (9) , 1470-1474
A Cross‐Sectional Questionnaire Survey on the Impact of Congenital Ichthyosis on Lifelong Education and Career
A cross‐sectional analysis was conducted to evaluate the impact of ichthyosis symptoms on the educational achievement and career choices of adults, or the potential future impact on children. A total of 77 respondents completed a questionnaire assessing the degree to which ichthyosis had impacted, or was expected to impact, their education and career. Responses were categorized as “none,” “somewhat,” or “greatly.” The data were analyzed in relation to the objective severity measures in our previous study, including the Clinical Ichthyosis Score (CIS) and QOL assessments, using Spearman's correlation coefficients. Of the 77 participants, 45.5% reported a great impact, 41.6% reported some impact, and 13.0% reported no impact. A significant positive correlation was observed between the perceived impact and CIS (rs = 0.402, p < 0.001), as well as between the perceived impact and QOL scores (16 ≤ age, rs = 0.462, p < 0.001; 4 ≤ age ≤ 15, rs = 0.822, p < 0.001; age ≤ 3, rs = 0.894, p = 0.106). Symptoms such as itching, pain, and social discomfort were identified as potential cumulative contributors to educational and occupational limitations. The findings suggest that higher disease severity and lower QOL are significantly associated with adverse educational and career outcomes in patients with congenital ichthyosis. (207/300 words).
- 22 July 2025
- Published by Wiley in The Journal of Dermatology
- Vol. 52 (9) , 1470-1474
A Cross‐Sectional Questionnaire Survey on the Impact of Congenital Ichthyosis on Lifelong Education and Career
A cross‐sectional analysis was conducted to evaluate the impact of ichthyosis symptoms on the educational achievement and career choices of adults, or the potential future impact on children. A total of 77 respondents completed a questionnaire assessing the degree to which ichthyosis had impacted, or was expected to impact, their education and career. Responses were categorized as “none,” “somewhat,” or “greatly.” The data were analyzed in relation to the objective severity measures in our previous study, including the Clinical Ichthyosis Score (CIS) and QOL assessments, using Spearman's correlation coefficients. Of the 77 participants, 45.5% reported a great impact, 41.6% reported some impact, and 13.0% reported no impact. A significant positive correlation was observed between the perceived impact and CIS (rs = 0.402, p < 0.001), as well as between the perceived impact and QOL scores (16 ≤ age, rs = 0.462, p < 0.001; 4 ≤ age ≤ 15, rs = 0.822, p < 0.001; age ≤ 3, rs = 0.894, p = 0.106). Symptoms such as itching, pain, and social discomfort were identified as potential cumulative contributors to educational and occupational limitations. The findings suggest that higher disease severity and lower QOL are significantly associated with adverse educational and career outcomes in patients with congenital ichthyosis. (207/300 words).
- 8 July 2025
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 50 (11) , 2291-2293
Thymoma-associated graft-versus-host disease-like skin eruptions: a case series and review
Thymoma-associated multiorgan autoimmunity (TAMA) is a rare but severe graft-versus-host disease-like disorder that presents with skin manifestations that are often misdiagnosed as drug eruptions. Given the critical importance of early recognition, we conducted a retrospective study of 14 patients with thymoma and skin symptoms. Among them, we identified four cases of TAMA, all initially misdiagnosed, with three associated with poor prognosis because of infection or disease progression. Our findings highlight the challenges of diagnosing TAMA and emphasize the need for heightened awareness and accurate histopathological assessment to improve patient outcomes.
- 8 July 2025
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 50 (11) , 2291-2293
Thymoma-associated graft-versus-host disease-like skin eruptions: a case series and review
Thymoma-associated multiorgan autoimmunity (TAMA) is a rare but severe graft-versus-host disease-like disorder that presents with skin manifestations that are often misdiagnosed as drug eruptions. Given the critical importance of early recognition, we conducted a retrospective study of 14 patients with thymoma and skin symptoms. Among them, we identified four cases of TAMA, all initially misdiagnosed, with three associated with poor prognosis because of infection or disease progression. Our findings highlight the challenges of diagnosing TAMA and emphasize the need for heightened awareness and accurate histopathological assessment to improve patient outcomes.
- Open Access
- 26 March 2025
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 193 (1) , 184-185
Estimating the proportions of allele frequencies for SERPINA12 pathogenic variants in Japanese patients with Nagashima-type palmoplantar keratosis/keratoderma
Nagashima-type palmoplantar keratoderma (NPPK) is the most common form of palmoplantar keratoderma in Asian populations and is primarily caused by biallelic variants in SERPINB7. As SERPINA12 variants were reported in Chinese patients with NPPK, we analysed SERPINA12 variants in 18 Japanese patients with NPPK lacking biallelic SERPINB7 variants and found significantly higher frequencies of SERPINA12 variants c.635-7A>G and c.656A>G compared with the general population. This suggests a potential digenic effect involving SERPINB7 and SERPINA12, highlighting the need for considering digenic inheritance in NPPK diagnosis and genetic counselling.
- 26 March 2025
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 193 (1) , 184-185
Open AccessEstimating the proportions of allele frequencies for SERPINA12 pathogenic variants in Japanese patients with Nagashima-type palmoplantar keratosis/keratoderma
Nagashima-type palmoplantar keratoderma (NPPK) is the most common form of palmoplantar keratoderma in Asian populations and is primarily caused by biallelic variants in SERPINB7. As SERPINA12 variants were reported in Chinese patients with NPPK, we analysed SERPINA12 variants in 18 Japanese patients with NPPK lacking biallelic SERPINB7 variants and found significantly higher frequencies of SERPINA12 variants c.635-7A>G and c.656A>G compared with the general population. This suggests a potential digenic effect involving SERPINB7 and SERPINA12, highlighting the need for considering digenic inheritance in NPPK diagnosis and genetic counselling.
- Open Access
- 13 May 2024
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 191 (3) , 397-404
Treating epidermolytic ichthyosis and ichthyosis with confetti with epidermal autografts cultured from revertant skin
No efficient treatment has been established yet for epidermolytic ichthyosis (EI) caused by pathogenic variants in KRT1 or KRT10. Patients with ichthyosis with confetti (IWC) show multiple normal-appearing spots, caused by the revertant somatic recombination of pathogenic variants that occurs at each spot independently. Additionally, some patients with EI have large areas of normal skin due to revertant postzygotic mosaicism. To assess the feasibility transplanting cultured epidermal autografts (CEAs) produced from revertant epidermal keratinocytes in patients with EI and IWC. We performed a clinical trial of treatment with CEAs produced from each patient’s own revertant epidermal keratinocytes as a proof-of-concept study. This is a single-arm, open (masking not used), uncontrolled, single-assignment, treatment purpose study. The primary outcome was the rate of areas without the recurrence of ichthyosis lesions 4 weeks after the final transplant (%). The secondary outcome was the rate of areas without the recurrence of ichthyosis lesions 24 weeks after initial transplantation (%). We successfully produced CEAs from the genetically confirmed revertant skin of the two mosaic EI patients and one IWC patient and genetically confirmed that CEAs mainly consist of revertant wild-type cells by amplicon sequencing and droplet digital PCR analysis. Single-cell RNA sequencing analysis confirmed the normal proliferation and safety profiling of CEAs. CEAs were transplanted to desquamated lesional sites of the patients. Four weeks after this transplantation, the rate of areas without the recurrence of ichthyosis lesions in the three cases was 39.52%, 100.0%, and 100.0% respectively, although the recurrence of ichthyosis lesions was seen at the site of CEA transplantation in all three patients at 24 weeks after transplantation. CEAs from normal skin have the potential to be a safe and local treatment option for EI and IWC. jRCTb041190097
- 13 May 2024
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 191 (3) , 397-404
Open AccessTreating epidermolytic ichthyosis and ichthyosis with confetti with epidermal autografts cultured from revertant skin
No efficient treatment has been established yet for epidermolytic ichthyosis (EI) caused by pathogenic variants in KRT1 or KRT10. Patients with ichthyosis with confetti (IWC) show multiple normal-appearing spots, caused by the revertant somatic recombination of pathogenic variants that occurs at each spot independently. Additionally, some patients with EI have large areas of normal skin due to revertant postzygotic mosaicism. To assess the feasibility transplanting cultured epidermal autografts (CEAs) produced from revertant epidermal keratinocytes in patients with EI and IWC. We performed a clinical trial of treatment with CEAs produced from each patient’s own revertant epidermal keratinocytes as a proof-of-concept study. This is a single-arm, open (masking not used), uncontrolled, single-assignment, treatment purpose study. The primary outcome was the rate of areas without the recurrence of ichthyosis lesions 4 weeks after the final transplant (%). The secondary outcome was the rate of areas without the recurrence of ichthyosis lesions 24 weeks after initial transplantation (%). We successfully produced CEAs from the genetically confirmed revertant skin of the two mosaic EI patients and one IWC patient and genetically confirmed that CEAs mainly consist of revertant wild-type cells by amplicon sequencing and droplet digital PCR analysis. Single-cell RNA sequencing analysis confirmed the normal proliferation and safety profiling of CEAs. CEAs were transplanted to desquamated lesional sites of the patients. Four weeks after this transplantation, the rate of areas without the recurrence of ichthyosis lesions in the three cases was 39.52%, 100.0%, and 100.0% respectively, although the recurrence of ichthyosis lesions was seen at the site of CEA transplantation in all three patients at 24 weeks after transplantation. CEAs from normal skin have the potential to be a safe and local treatment option for EI and IWC. jRCTb041190097
- 14 February 2023
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 37 (6) , E779-E781
A case of advanced diffuse large B‐cell lymphoma diagnosed from widespread superficial mycosis of the skin
- 14 February 2023
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 37 (6) , E779-E781
A case of advanced diffuse large B‐cell lymphoma diagnosed from widespread superficial mycosis of the skin
- 18 January 2023
- Published by Wiley in The Journal of Dermatology
- Vol. 50 (7) , E206-E207
Cutaneous manifestations of microscopic polyangiitis successfully controlled with avacopan alone
- 18 January 2023
- Published by Wiley in The Journal of Dermatology
- Vol. 50 (7) , E206-E207
Cutaneous manifestations of microscopic polyangiitis successfully controlled with avacopan alone
- Open Access
- 14 July 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (14) , 7791
Deep Phenotyping of Superficial Epidermolytic Ichthyosis due to a Recurrent Mutation in KRT2
Superficial epidermolytic ichthyosis (SEI) is an autosomal dominant inherited ichthyosis. SEI is caused by mutations in KRT2 and frequently shows erythroderma and widespread blistering at birth. We report the clinical manifestations of two patients from a Japanese family with SEI caused by a hotspot mutation, p.Glu487Lys, in KRT2. In addition, we summarize previous reports on SEI patients with the identical mutation. One of the two patients had disease onset at the age of 7 months. The other patient’s age of onset is unknown, but it was in childhood. Neither of the two patients showed erythroderma. To perform deep phenotyping, we studied the age of onset and the frequency of erythroderma in 34 reported SEI cases with the p.Glu487Lys mutation, including the present cases. Among the cases with sufficient clinical information, 44.4% of the cases that were due to p.Glu487Lys in KRT2 occurred at birth. Erythroderma was observed in 11.1% of the cases with p.Glu487Lys in KRT2.
- 14 July 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (14) , 7791
Open AccessDeep Phenotyping of Superficial Epidermolytic Ichthyosis due to a Recurrent Mutation in KRT2
Superficial epidermolytic ichthyosis (SEI) is an autosomal dominant inherited ichthyosis. SEI is caused by mutations in KRT2 and frequently shows erythroderma and widespread blistering at birth. We report the clinical manifestations of two patients from a Japanese family with SEI caused by a hotspot mutation, p.Glu487Lys, in KRT2. In addition, we summarize previous reports on SEI patients with the identical mutation. One of the two patients had disease onset at the age of 7 months. The other patient’s age of onset is unknown, but it was in childhood. Neither of the two patients showed erythroderma. To perform deep phenotyping, we studied the age of onset and the frequency of erythroderma in 34 reported SEI cases with the p.Glu487Lys mutation, including the present cases. Among the cases with sufficient clinical information, 44.4% of the cases that were due to p.Glu487Lys in KRT2 occurred at birth. Erythroderma was observed in 11.1% of the cases with p.Glu487Lys in KRT2.